#7: The IPO Freeze, tariff volatility, peak private valuations, and Colossal Biosciences stock

The IPO freeze is here. Craig unpacks the impact of tariff volatility on the IPO markets, and he explores the possibility that private AI valuations have peaked. Plus, Colossal Biosciences and the de-extinction of the dire wolf.Subscribe to the Access IPOs NewsletterJoin the Access ClubDeal alerts and bonus content0:00 Intro0:50 The IPO Freeze2:23 6 Paused IPOs3:24 Cerebras IPO3:58 IPO Thaw?4:52 Volatility Index (VIX)6:18 Maintaining S-1 Filings8:10 IPO Pipeline9:45 IPO Radar News10:23 Peak Private Valuations11:22 Figure AI WSJ13:29 Scale AI Valuation15:13 Colossal Biosciences15:49 Dire Wolf16:15 De-Extinction16:47 Colossal Bio Funding Rounds15:13 IPO Radar Selection18:04 VC Investors18:35 Colossal Bio Business Model19:25 Dodo Bird19:35 Can You Invest in Colossal?20:50 Jurassic Tweet21:10 Programming Note21:26 Support the Show24:04 OutroThis video is for informational purposes only. Mentions are not a recommendation to buy or sell any pre-IPO or public company. Invest in IPOs and private companies at your own risk.